Meetings

The Orion Conference: Turning Big Data Into Knowledge

A conference in Cambridge, Massachusetts, outlined progress and challenges in turning computational modeling into actionable knowledge in MS and other brain disorders

I’d like to tell you about a conference that Orion Bionetworks hosted at the...

Clinical Research, Drug Development, Laboratory Research, Meetings, Methods

Refined Animal Model Led to Phenytoin Clinical Trial

In 2010, Professor David Baker was awarded an NC3Rs Project Grant to develop a...

An animal model that presents an alternative to EAE suggested a role for sodium channel blockers in neuroprotection. This led directly to a successful human trial of phenytoin, which was presented at last week’s AAN meeting.

Clinical Research, Drug Development, Laboratory Research, Meetings, Methods

Seeking Answers for Progressive MS

An invitational meeting in Boston marks a step forward in a concerted international push to find effective therapies to target disease mechanisms, manage symptoms, and improve rehabilitation

A meeting in Boston early in March drew more than 80 scientists and clinical researchers to address...

Clinical Research, Drug Development, Laboratory Research, Meetings

CMSC Indiana Meeting to Go On Despite “Religious Freedom” Law

Last Friday, the state of Indiana passed the “Religious Freedom Restoration Act.” The act, signed into law by...

The Consortium of Multiple Sclerosis Centers will not be canceling its annual meeting, scheduled for May 27-30 in Indianapolis

Meetings, People

Help Keep MSDF Alive!

Do you find MSDF invaluable? If so, please help us continue by making a tax-deductible donation NOW.

If you’re reading this message, it’s because you’re one of the 16,000 unique...

Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People

“Long Life” Protein Klotho Powers Remyelination in Mice

Klotho is known to play a role in a number of age-related diseases, such as Alzheimer’s. New research suggests that a small molecule that boosts production of this protein may enhance maturation of OPCs into myelin-producing cells.

According to Greek myth, Clotho was the youngest of the three Morai, the trio of fates responsible for...

Laboratory Research, Meetings

159 Genetic Variants Now Known to Be Associated With MS

The International MS Genetics consortium recently identified more than 45 new genetic variants associated with susceptibility to multiple sclerosis, many of which are involved in brain function

The list of genetic variants associated with multiple sclerosis grew even longer earlier this year at the...

Clinical Research, Laboratory Research, Meetings

The Paradox of Daclizumab

Phase 3 results show that daclizumab reduces disease activity in relapsing-remitting multiple sclerosis by half compared with interferon, as measured by brain imaging, with skin and other side effects. The drug works in surprising ways that are revealing new details about the pathogenesis of MS.

Three might be the lucky number for daclizumab, an investigational drug for relapsing-remitting multiple sclerosis with...

Clinical Research, Drug Development, Laboratory Research, Meetings

MS Research Roundup: September 22, 2014

#MSBoston2014 Special Edition; Collected Meeting News & Videos; Video Games & Cognitive Function; Measuring Neurodegeneration With Retinal Thinning

Items of interest to multiple sclerosis researchers from around the Web...

Clinical Research, Meetings

ACTRIMS-ECTRIMS 2014 -- Day 4

The meeting's final day featured late breakers, the closing lecture, and two masterful summaries of research highlights

Last day of #ACTRIMS #ECTRIMS 2day! L8 breaking news & closing plenary-awards...

Clinical Research, Drug Development, Laboratory Research, Meetings, Methods, People

Multiple Sclerosis Discovery Forum

Inspiring Connections

Utility Navigation

User Top Menu